| Cat. # | Description | Qty. | Unit |
| 221848 | CIN Agar (Yersinia Selective) | 10 | SP |
CIN (cefsulodin-Irgasan-novobiocin) Agar is a differential and selective medium used in qualitative procedures for the isolation of Yersinia enterocolitica from a variety of clinical and nonclinical specimens.
| Catalog # | Description | Quantity | Unit |
| 221848 | CIN Agar (Yersinia Selective) | 10 | SP |
CIN (cefsulodin-Irgasan-novobiocin) Agar is a differential and selective medium used in qualitative procedures for the isolation of Yersinia enterocolitica from a variety of clinical and nonclinical specimens.
CIN Agar was first described by Schiemann as an alternative to MacConkey Agar and other commonly used media for isolation of Yersinia enterocolitica, a causative agent of gastroenteritis.1 CIN Agar has been found to be far superior to MacConkey, SS, CAL or Y agars.2
See "Quality Control Procedures."
Quality control requirements must be performed in accordance with applicable local, state and/or federal regulations or accreditation requirements and your laboratory's standard Quality Control procedures. It is recommended that the user refer to pertinent CLSI (formerly NCCLS) guidance and CLIA regulations for appropriate Quality Control practices.
| CIN Agar | |||||
| Approximate Formula* Per Liter Purified Water | |||||
| Pancreatic Digest of Gelatin | 10.0 | g | |||
| Peptic Digest of Animal Tissue | 5.0 | g | |||
| Beef Extract | 5.0 | g | |||
| Yeast Extract | 2.0 | g | |||
| Mannitol | 20.0 | g | |||
| Sodium Pyruvate | 2.0 | g | |||
| Sodium Chloride | 1.0 | g | |||
| Magnesium Sulfate | 0.001 | g | |||
| Sodium Desoxycholate | 0.5 | g | |||
| Agar | 12.0 | g | |||
| Crystal Violet | 0.001 | g | |||
| Neutral Red | 0.03 | g | |||
| Cefsulodin | 15.0 | mg | |||
| Irgasan | 4.0 | mg | |||
| Novobiocin | 2.5 | mg | |||
| *Adjusted and/or supplemented as required to meet performance criteria. | |||||
For in vitro Diagnostic Use.
If excessive moisture is observed, invert the bottom over an off-set lid and allow to air dry in order to prevent formation of a seal between the top and bottom of the plate during incubation.
Pathogenic microorganisms, including hepatitis viruses and Human Immunodeficiency Virus, may be present in clinical specimens. "Standard Precautions"3-6 and institutional guidelines should be followed in handling all items contaminated with blood and other body fluids. After use, prepared plates, specimen containers and other contaminated materials must be sterilized by autoclaving before discarding.
Information shown on this page is a short summary extracted from the QC/PI Manual, available as a PDF under the Related Documents section of this page.